通过囊酸调节Kv7通道电流
DanDan Geng1, Yaning Li1, Rong Zheng1
1The Key Laboratory of Neural and Vascular Biology, Ministry of Education (D.D.G., Y.L., R.Z., B.Y., F.Z.), Department of Biochemistry and Molecular Biology (D.D.G., Y.L., R.Z., B.Y., F.Z.), The Core Facilities and Centers (H.Z.), and School of Pharmacy (Y.Z.), Hebei Medical University, Shijiazhuang, China.
Molecular pharmacology
|June 6, 2023
概括
五环三烯,包括囊酸,抑制Kv7通道. 乙酸是Kv7.2/Kv7.3和其他Kv7通道的强有力的抑制剂,为研究神经元刺激障碍提供了一个新的工具.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- Kv7/M通道是治疗神经元刺激障碍的关键目标,如,疼痛和抑郁症.
- 五环三烯具有多种药理作用,包括抗炎和抗抑郁作用.
研究的目的:
- 研究各种五环三烯对Kv7通道功能的影响.
- 在五环三烯中发现kv7通道的强有力的抑制剂.
主要方法:
- 用电生理学记录来评估五环三烯对Kv7.2/Kv7.3通道的抑制作用.
- 对强效抑制剂进行了剂量反应关系和动力学分析.
- 在不同的Kv7通道亚型 (Kv7.1-Kv7.5) 中评估了抑制剂的选择性.
主要成果:
- 一些五环三烯,包括乙囊酸,乌尔松酸和油酸,抑制了Kv7.2/Kv7.3通道电流.
- 乙酸表现出最高的强度 (IC50 = 2.5μM),并显著改变了Kv7.2/Kv7.3通道动力学和电压依赖.
- 乙酸在Kv7.1-Kv7.5通道亚型中表现出非选择性抑制.
结论:
- 乙酸是一种神经元Kv7通道的新型和强大的抑制剂.
- 这些发现突显了囊酸作为药理学工具的潜力,用于探索神经系统疾病中的Kv7通道功能.
相关概念视频
Voltage-gated Ion Channels
8.3K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.3K
Antiepileptic Drugs: Potassium Channel Activators
219
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
219
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
351
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
351
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K


